Midregional proatrial naturetic peptide (MRproANP) and copeptin (COPAVP) as predictors of all-cause mortality in recently diagnosed mild to moderate COPD-results from COSYCONET
中段前心房利尿肽 (MRproANP) 和血管加压素 (COPAVP) 作为近期诊断的轻度至中度 COPD 患者全因死亡率的预测因子——来自 COSYCONET 的研究结果
期刊:Respiratory Research
影响因子:5
doi:10.1186/s12931-024-02690-9
Fähndrich, S; Herr, C; Teuteberg, S; Alter, P; Söhler, S; Soriano, D; Classen, J; Adams, J; Weinhold, V; Watz, H; Waschki, B; Zeller, T; Eichenlaub, M; Trudzinski, F C; Michels, J D; Omlor, A; Seiler, F; Moneke, I; Biertz, F; Stolz, D; Welte, T; Kauczor, H U; Kahnert, K; Jörres, R A; Vogelmeier, C F; Bals, R